JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pain, S. J.
Right arrow Articles by Peters, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pain, S. J.
Right arrow Articles by Peters, A. M.

Quantification of Lymphatic Function for Investigation of Lymphedema: Depot Clearance and Rate of Appearance of Soluble Macromolecules in Blood

Simon J. Pain, MA1, R. Steven Nicholas, PhD2, Robert W. Barber, MSc2, James R. Ballinger, PhD2, Arnie D. Purushotham, MD1, Peter S. Mortimer, MD3 and A. Michael Peters, MD2

1 Cambridge Breast Unit, Addenbrooke’s Hospital, Cambridge, United Kingdom
2 Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom
3 Department of Medicine, St. George’s Hospital Medical School and The Royal Marsden National Health Service Trust, London, United Kingdom



View larger version (25K):

[in a new window]
 
FIGURE 1. Pooled depot clearance data (plotted as mean natural logarithm [ln] of remaining activity) with trend lines from which rate removal constant k (% . min-1) is calculated for HSA (n = 6) (A) and HIgG (n = 12) (B) with error bars showing 1 SD.

 


View larger version (18K):

[in a new window]
 
FIGURE 2. Pooled venous activity profiles for HSA (n = 6) (A) and HIgG (n = 12) (B). %/l = percentage of administered activity per liter of blood.

 


View larger version (18K):

[in a new window]
 
FIGURE 3. Rate removal constant, k (in % . min-1), plotted against total venous activity at 3 h (% injected activity) for HSA (A and B) and HIgG (C and D). • = 111In in healthy volunteers; {circ} = 111In in preoperative patients; {blacktriangleup} = 99mTc in healthy volunteers; {triangleup} = 99mTc in preoperative patients.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.